0001925468-23-000001.txt : 20230504 0001925468-23-000001.hdr.sgml : 20230504 20230504102218 ACCESSION NUMBER: 0001925468-23-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20230504 DATE AS OF CHANGE: 20230504 EFFECTIVENESS DATE: 20230504 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QuantBio Innovations Fund LP CENTRAL INDEX KEY: 0001925468 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-444527 FILM NUMBER: 23886955 BUSINESS ADDRESS: STREET 1: C/O OBERLAND CAPITAL MANAGEMENT LLC STREET 2: 1700 BROADWAY, 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-257-5850 MAIL ADDRESS: STREET 1: C/O OBERLAND CAPITAL MANAGEMENT LLC STREET 2: 1700 BROADWAY, 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 D/A 1 primary_doc.xml X0708 D/A LIVE 0001925468 QuantBio Innovations Fund LP C/O OBERLAND CAPITAL MANAGEMENT LLC 1700 BROADWAY, 37TH FLOOR NEW YORK NY NEW YORK 10019 212-257-5850 DELAWARE None None Limited Partnership true 2021 JEAN-PIERRE NAEGELI C/O OBERLAND CAPITAL MANAGEMENT LLC 1700 BROADWAY, 37TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer ANDREW RUBINSTEIN C/O OBERLAND CAPITAL MANAGEMENT LLC 1700 BROADWAY, 37TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0001925468-22-000001 2022-05-09 true true false 0 Indefinite 3836000 Indefinite false 12 0 0 0 false QuantBio Innovations Fund LP DAVID DUBINSKY DAVID DUBINSKY AUTHORIZED SIGNATORY OF THE GENERAL PARTNER 2023-05-03